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Abstract It has been proposed that the REV1 protein plays an
important role in the induced-mutagenesis pathway. We show
that purified REV1 protein inserts dCMP opposite template G,
A, T and C, and dGMP and dTMP opposite template G in the
presence of magnesium, while in the presence of manganese the
specificity for dCMP was found to be relaxed and the REV1
protein acquired the ability to insert dCMP, dGMP, dAMP and
dTMP opposite templates G, A, T, and C. Kinetic analysis
provided evidence for high affinity for dCTP with template G,
suggesting that the REV1 protein is specialized for dCTP and
template G. ) 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
The damage-induced mutagenesis pathway is a tightly regu-
lated cellular function. Genetic studies in Saccharomyces ce-
revisiae have contributed to the discovery of genes required
for the mutagenesis, including RAD6, RAD18, REV1, REV3,
and REV7 [1^5]. Mutations in the RAD6 and RAD18 genes
disrupt the tight regulation so that strong sensitivity to a wide
range of DNA-damaging agents is exhibited [6]. Rad6, one of
13 ubiquitin-conjugating enzymes in S. cerevisiae, forms het-
erodimers with Rad18, the complex possessing single-stranded
DNA-binding and ATPase activities [7^9]. It has been postu-
lated to recognize single-stranded gaps and activate the dam-
age-induced mutagenesis pathway. The rev mutants were ini-
tially isolated by reduced mutations after UV treatment [1].
REV3 encodes the catalytic subunit of DNA polymerase j,
which also contains Rev7, capable of translesion DNA syn-
thesis [10]. This DNA polymerase is speci¢cally required for
damage-induced mutagenesis in yeast.
Rev1 belongs to the Y family of DNA polymerases [11]. It
contains a BRCT domain at its N-terminus and possesses
dCMP transferase activity in a template-directed reaction
[12]. However, the main role of the REV1 gene in the muta-
genesis pathway is not due to action as a deoxyribonucleotidyl
transferase. Although the Rev1 protein does not allow bypass-
ing T-T (6-4) photoproducts in vitro, the gene is required for
translesion DNA synthesis in vivo [13]. A mutagenesis-de¢-
cient mutant has a mutation in the BRCT domain but the
encoded protein retains normal dCMP transferase activity
[13], and methyl methanesulfonate-induced mutagenesis has
been shown to be normal in a site-directed mutant lacking
dCMP transferase activity [14]. Therefore, the main function
of the Rev1 protein may be to incorporate a large complex
with DNA polymerase j, by protein^protein interactions [14].
The damage-induced mutagenesis pathway is evolutionarily
conserved from yeast to humans. The genes involved in yeast
have mammalian homologues, including HR6A, HR6B,
RAD18, REV1, REV3 and REV7 [15^24]. The human
REV1 protein contains a BRCT domain at the N-terminus
like the yeast Rev1 protein [19,20,23] and a domain required
for binding to the human REV7 protein at the C-terminus
[24]. Since these domains are not required for dCMP trans-
ferase activity [23], their conservation may further point to an
importance for incorporation of large complexes with DNA
polymerase j.
In the present study, we developed a method to purify the
REV1 protein without any tags for rapid puri¢cation, and
investigated the enzyme properties using the intact protein.
The intact REV1 protein may be suitable for investigations
of protein^protein interactions in the mutagenesis pathway.
2. Materials and methods
2.1. Construction of a REV1 expression plasmid
To remove the portion encoding a histidine tag from the h6-REV1S
expression plasmids, pBAD-REV1S and pBAD-REV1SA [23], each
was digested with NdeI and EcoRV, and the respective NdeI^EcoRV
fragments were inserted into the corresponding site of the pET20b(+)
vector (Invitrogen). XbaI fragments of each of the resulting plasmids
(pET-I-REV1S and pET-I-REV1SA), containing the Shine^Dalgarno
sequence and the start codon of the REV1S cDNA, were replaced
with the corresponding fragment of pBAD-REV1S [23]. The resulting
plasmids pBAD-I-REV1S and pBAD-I-REV1SA produce wild type
and mutant type (D569A/E570A) proteins, respectively. They contain
the araC gene and the pBAD promoter of the arabinose operon, and
gene expression is consequently induced by L-(+)-arabinose (Fig. 1).
2.2. Overproduction and puri¢cation of human REV1 protein
The bacterial strain, BL21(DE3) [25], harboring pBAD-I-REV1S
was inoculated into 40 ml of Luria broth supplemented with ampicil-
lin (100 Wg/ml). Cells were grown at 15‡C for 24 h with vigorous
shaking. This starter culture was transferred into 2 l of SB medium
(32 g NZ-amine/20 g yeast extract/5 g NaCl/0.5 ml 10 M NaOH, all
per liter) [26] supplemented with ampicillin (250 Wg/ml), and cells were
further grown at the same temperature. The doubling time of the cells
was 5.5 h under these conditions. When the A600 value reached 0.6,
20 g of L-(+)-arabinose was added and incubation was continued for
11 h. Then cells were harvested by centrifugation at 4‡C. The resultant
cell paste (12 g) was resuspended in 24 ml bu¡er I (50 mM HEPES^
NaOH, pH 7.5/1 M NaCl/0.1 mM EDTA/10 mM L-mercaptoethanol)
at 4‡C, frozen in liquid nitrogen and stored at 380‡C. The frozen cells
were thawed in ice water with shaking, and lysed after addition of
phenylmethylsulfonyl £uoride to 1 mM by introduction of 4 ml of
bu¡er I containing 100 mM spermidine and 4 mg/ml lysozyme. The
cells were incubated on ice for 30 min, heated in a 37‡C water bath for
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2 min with mild mixing, and then further incubated on ice for 30 min.
The cell lysate was clari¢ed by centrifugation at 35 000Ug for 30 min
at 4‡C and 25 ml of clari¢ed supernatant was obtained (fraction I;
25 ml, 250 mg protein).
The following column chromatography was carried out at 4‡C us-
ing an FPLC system (Pharmacia). Fraction I was mixed with 240 Wl of
bu¡er A (50 mM HEPES^NaOH, pH 7.5/1 M NaCl/10% glycerol/10
mM L-mercaptoethanol) containing 1 M imidazole and applied at 0.2
ml/min to a 1-ml HiTrap chelating column (Pharmacia), which had
been treated with 2 ml of 0.5 M NiSO4 and equilibrated with bu¡er A
containing 10 mM imidazole. The column was washed with 15 ml of
equilibration bu¡er at 0.1 ml/min and then the REV1 protein was
eluted with 10 ml of a linear gradient of 10^100 mM imidazole in
bu¡er A and collected in 500-Wl fractions. A sample (5 Wl) of each
fraction was analyzed by SDS^PAGE and peak fractions containing
the REV1 protein, eluted in a main peak at the beginning of the
gradient, were pooled (fraction II; 2.5 ml, 6.3 mg protein) and dia-
lyzed against bu¡er B (50 mM HEPES^NaOH, pH 7.5/10% glycerol/
10 mM L-mercaptoethanol) containing 400 mM NaCl.
Fraction II was then loaded at 0.1 ml/min onto a 1-ml HiTrap
heparin column (Pharmacia) equilibrated with the dialysis bu¡er.
The column was washed with 10 ml of the equilibration bu¡er and
the REV1 protein was eluted with 10 ml of a linear gradient of 400^
700 mM NaCl in bu¡er B and collected in 500-Wl fractions. A sample
(5 Wl) of each fraction was analyzed by SDS^PAGE and the peak
fraction containing REV1 protein, which was eluted in a main peak
at about 550 mM NaCl, was collected (fraction III; 500 Wl, 150 Wg
protein).
Fraction III was then applied at 0.1 ml/min to a Superdex 200 HR
10/30 column (Pharmacia) equilibrated with bu¡er B containing 500
mM NaCl, and 500-Wl fractions were collected. The peak fractions of
REV1 protein were pooled, frozen in liquid nitrogen and stored at
380‡C (fraction IV; 1 ml, 135 Wg protein). Protein concentrations
were determined by the Bio-Rad protein assay using bovine serum
albumin (BSA; Bio-Rad) as the standard.
The mutant form of the REV1 protein, D569A/E570A, was over-
produced in BL21(DE3) harboring pBAD-I-REV1SA plasmid and
puri¢ed as for the wild type protein.
2.3. Transferase assays
Oligonucleotide templates 5P-CTCGTCAGCATCTTCAXCATA-
CAGTCAGTG-3P (X=G; 30G, A; 30A, T; 30T, C; 30C, tetrahy-
drofuran; 30F) and the primer 5P-CACTGACTGTATG-3P (P13) were
purchased [23]. The latter was labeled using polynucleotide kinase
(New England Biolabs) and [Q-32P]ATP (Amersham Pharmacia Bio-
tech), and annealed to the templates. The standard reaction mixture
(25 Wl) contained 50 mM Tris^HCl bu¡er, pH 8.0, 25 mM
(NH4)2SO4, 0.1 mg/ml BSA, 5 mM dithiothreitol, 0.1 mM dNTP,
100 nM primer template, indicated amounts of divalent cations and
1 Wl of protein sample, diluted with bu¡er B containing 500 mM NaCl
and 0.1 mg/ml BSA as indicated. After incubation at 30‡C for the
indicated time, reactions were terminated with 10 Wl of stop solution
(30 mM EDTA/94% formamide/0.05% bromophenol blue/0.05% xy-
lene cyanol) and products were resolved on 20% polyacrylamide gels
containing 8 M urea and autoradiographed at 380‡C. The amount of
DNA present in each band was quanti¢ed using a Bio-Imaging Ana-
lyzer BAS2000 (Fuji Photo Film).
3. Results
3.1. Puri¢cation of the intact human REV1 protein from
overproducing Escherichia coli cells
Human REV1 expression from pBAD-I-REV1S, under
control of the pBAD promoter, was induced by addition of
arabinose (Fig. 1). When the cells were grown at 37‡C,
many bands of degradation products of the REV1 protein
were detected by Western blotting (data not shown). The de-
graded fractions were much reduced when the cells were
grown at 15‡C and a clear 150-kDa band was observed
(Fig. 2, lane 3). We used those cells as the starting material
for puri¢cation of human REV1 protein.
As REV1 protein is readily precipitated at low salt concen-
trations [19], a crude lysate was prepared in the presence of
1 M NaCl and a large amount of induced REV1 protein was
recovered in the soluble fraction (Fig. 2, lane 4). We found the
intact REV1 protein to have an a⁄nity for the nickel-chelat-
ing column. This ¢nding facilitated the puri¢cation. The
REV1 protein, but not the majority of E. coli proteins, bound
to the column in the presence of 10 mM imidazole and eluted
on increasing the imidazole gradient. In this chromatography
step, REV1 represented the major band in peak fractions
(Fig. 2, lane 5). After dialysis against bu¡er containing 400
mM NaCl, no precipitate was observed. Then the sample was
Fig. 1. Structure of the REV1 expression plasmid. The human
REV1 gene is under the control of the pBAD promoter regulated by
the araC gene, whose transcription is induced by arabinose. +1 rep-
resents the position of the 5P-terminus of the transcript [30]. The in-
duced protein is a short form of the REV1 protein, REV1S [23].
Fig. 2. Results of SDS^PAGE showing overproduction and stages
of puri¢cation of wild type (lanes 2^7) and D569A/E570A (lane 8)
REV1 from E. coli. Lane 1, molecular weight markers (Invitrogen);
lanes 2 and 3, total E. coli proteins before and after induction with
arabinose, respectively; lane 4, crude E. coli lysate (fraction I,
25 Wg); lane 5, pooled fractions eluted from the nickel-chelating col-
umn (fraction II, 3 Wg); lane 6, the peak fraction eluted from the
heparin column (fraction III, 0.6 Wg); lanes 7 and 8, pooled frac-
tions eluted from the gel ¢ltration column (fraction IV, 0.5 Wg).
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loaded onto a heparin column. In the presence of 400 mM
NaCl, almost all E. coli proteins were found in the £ow-
through fraction, but REV1 protein was bound and eluted
at about 550 mM NaCl (Fig. 2, lane 6). For further puri¢ca-
tion, the peak fraction from heparin chromatography was
applied to a Superdex 200 column (Pharmacia). The REV1
protein eluted with an apparent molecular mass of 380 kDa
and a Stokes radius of 59 AT . Analysis by SDS^PAGE re-
vealed a full-length REV1 protein of 150 kDa and minor
contaminating degraded forms (Fig. 2, lane 7), detected spe-
ci¢cally when the REV1 protein was induced in E. coli cells
(data not shown). The mutant REV1 protein, D569A/E570A,
was puri¢ed by exactly the same procedures (Fig. 2, lane 8).
In these puri¢ed protein fractions, neither DNA polymerase
nor deoxyribonuclease activities were detected (Fig. 3C,D,
data not shown).
3.2. Optimum conditions for the transferase reaction
To test the reaction conditions for dCMP transferase activ-
ity of the REV1 protein, glycerol was ¢rst omitted from the
reaction bu¡er because it had a slight inhibitory e¡ect and
increased the rate of dCMP insertion opposite the template
adenine. Next, bu¡er system conditions and pH were inves-
tigated using sodium phosphate, potassium phosphate,
HEPES^NaOH, and Tris^HCl bu¡ers. Maximal activity was
observed between pH 7.8 and 8.5 and Tris^HCl, but not
HEPES^NaOH, exerted an enhancing e¡ect. Then we tested
the e¡ects of increasing concentrations of sodium sulfate, so-
dium chloride, sodium acetate, potassium chloride, potassium
acetate, ammonium chloride, ammonium acetate and ammo-
nium sulfate. We found these were stimulatory at low concen-
trations. We selected 25 mM ammonium sulfate because it
produced good stimulation and decreased the rate of dCMP
insertion opposite adenine.
3.3. E¡ects of divalent cations
Divalent cations are an absolute requirement for transferase
reactions. When the e¡ects of magnesium chloride, manganese
chloride and calcium chloride were tested (Fig. 3), maximal
activity was observed in the reaction with 2 mM magnesium
chloride (Fig. 3A). Manganese chloride also supported the
transferase reaction at low concentrations, the titration curve
demonstrating a sharp peak at 0.1 mM, with strong inhibition
on increasing the concentration (Fig. 3A). This suggested the
a⁄nity of manganese for the REV1 protein was higher than
that of magnesium, but the e⁄ciency for catalysis lower. This
idea was supported by an experiment in which the e¡ects of
manganese chloride were analyzed in the presence of 5 mM
magnesium chloride (Fig. 3B). The results showed manganese
to exert inhibitory e¡ects on the transferase reaction with
Fig. 3. The e¡ects of divalent cations. A: Titration of divalent cations. The 5P-32P-labeled primer P13 was annealed with the template 30G
(P30G). Aliquots of 10 ng REV1 protein were incubated with P30G and dCTP under standard reaction conditions with the indicated concen-
trations of magnesium chloride (open circles), manganese chloride (closed circles) or calcium chloride (open squares) at 30‡C for 10 min. The
reaction products were resolved in 20% polyacrylamide gels containing 8 M urea, the band intensities of substrates and products were deter-
mined using a Bio-Imaging Analyzer BAS2000, and the amounts (in pmol) of products in 25 Wl of reaction solution were calculated. B: Inhibi-
tory e¡ects of manganese chloride and calcium chloride in the presence of 5 mM magnesium chloride. Aliquots of 10 ng REV1 protein were in-
cubated with P30G and dCTP under standard reaction conditions with 5 mM magnesium chloride and the indicated concentrations of calcium
chloride (open circles) or manganese chloride (closed circles) at 30‡C for 10 min. C: Substrate speci¢city of the transferase reactions. The
5P-32P-labeled primer, P13, was annealed with each of the templates, 30G (panels a and e), 30A (panels b and f), 30T (panels c and g), 30C
(panels d and h). The nucleotide sequences adjacent to the primer terminus are shown at the top of each panel. Aliquots of 10 ng REV1 pro-
tein and the indicated primer template were incubated with no dNTP (3), a single dNTP (G, A, T, C), or all four dNTPs (N) under standard
reaction conditions with 2 mM magnesium chloride (panels a^d) or 1 mM manganese chloride (panels e^h) at 30‡C for 10 min. The reaction
products were resolved in 20% polyacrylamide gels containing 8 M urea and visualized by autoradiography. D: Transferase reactions with a
mutant form of the REV1 protein, D569A/E570A. Aliquots of 100 ng D569A/E570A protein and P13G were incubated with no dNTP (3), a
single dNTP (G, A, T, C), or all four dNTPs (N) under standard reaction conditions with 2 mM magnesium chloride (panel a) or 1 mM man-
ganese chloride (panel b) at 30‡C for 10 min.
FEBS 26129 27-5-02
Y. Masuda, K. Kamiya/FEBS Letters 520 (2002) 88^9290
magnesium (Fig. 3B). Calcium chloride could not support the
catalysis at concentrations between 0.02 mM and 20 mM
(Fig. 3A, data not shown) and inhibitory e¡ects were shown
in the presence of 5 mM magnesium chloride (Fig. 3B). The
inhibition curve of calcium was identical to that of manganese
(Fig. 3B), suggesting similar a⁄nities of the two cations for
the REV1 protein.
Then substrate speci¢city of the transferase reaction was
analyzed in the presence of di¡erent divalent cations. In the
presence of magnesium, REV1 protein inserts dCMP opposite
template G, A, T and C, and dGMP and dTMP opposite
template G (Fig. 3C, panels a^d) [27]. The REV1 protein
has a weak ability to extend a mismatch terminus (Fig. 3C,
panel c). In the presence of manganese, REV1 transferred
dGMP, dAMP, dTMP and dCMP opposite all the templates
examined (Fig. 3C, panels e^h). However, in the presence of
all four dNTPs, the dCMP transferase reaction predominated.
Of the transferase reactions for dGMP, dAMP and dTMP,
template G proved to be the most e⁄cient substrate (Fig. 3C,
panels e^h). Templates A, T and C were less e⁄cient, even
though the respective dTMP, dAMP and dGMP transfer re-
actions made Watson^Crick base pairs (Fig. 3C, panels e^h).
It seems likely that REV1 is specialized for transfer of dNMP
moieties to template G.
To determine whether activity is intrinsic to the REV1 pro-
tein, we examined a mutant, D569A/E570A, which lacks
transferase activity [23,27]. Even with 100 ng protein, 10 times
the wild type protein amount, no activity was observed on
incubation with magnesium or manganese (Fig. 3D).
3.4. Steady-state kinetics of the transferase reactions
Kinetic parameters were determined by steady-state gel ki-
netic assays under de¢ned optimum conditions (Table 1). The
assays were all carried out with 5 min incubation, because the
time course of the reactions was linear until 10 min (data not
shown). In the dCMP transferase reaction, the template nu-
cleotides slightly a¡ected kcat values, which were 3.0, 3.1, 1.6
and 1.8 min31 opposite templates G, A, T and C respectively.
The template nucleotides strongly a¡ected the Km value for
dCTP (Table 1). The a⁄nity of dCTP for template G was 43,
330 and 310 times higher than for templates A, T and C,
respectively.
The REV1 protein possesses an activity capable of inserting
a dCMP opposite AP site [12,19]. The velocity of the reaction
with template AP site was 1.5 times faster than the reaction
with template G, while the a⁄nity of dCTP for template AP
site was 14 times lower than for template G.
4. Discussion
In the present study, a method was established to purify
human REV1 protein without any tags, and conditions for
the dCMP transferase reaction were optimized. These were
then applied to determine kinetic parameters. The results re-
vealed high e⁄ciency for the dCMP transferase reaction with
template G, in line with the earlier report of speci¢c transfer
of dCMP opposite template G by mouse Rev1 [27]. However,
the mammalian REV1 protein seems to have a lower ¢delity
than the yeast protein [28]. Previously, we showed that the
reaction e⁄ciency was strongly a¡ected by the surrounding
nucleotide sequence [27]. It is also possible that the di¡erence
is due to the assay conditions.
Substrate speci¢city was strongly a¡ected by a variety of
divalent cations, magnesium chloride limiting the transferase
reaction to dCMP, except with the G template, while manga-
nese chloride disrupted the speci¢city. Thus with manganese,
REV1 protein transferred all four dNTPs opposite templates
G, A, T and C. On the other hand, calcium chloride did not
support any transferase activity. In this context it is of interest
that Ling et al. [29] described a calcium ion to be chelated in
an active site of crystal DNA polymerase IV of Sulfolobus
solfataricus P2, a Y-family DNA polymerase including
REV1 protein. We have shown 0.5 mM calcium chloride to
completely inhibit the transferase reaction with 5 mM magne-
sium chloride, suggesting that calcium binds to the REV1
protein, consistent with the crystallographic ¢nding.
Human REV1 protein contains a BRCT domain at its
N-terminus [19,20,23] and a domain required for binding to
human REV7 at its C-terminus [24]. The BRCT domain may
be necessary for binding unidenti¢ed factor(s) to regulate en-
zyme activity [13]. Haracska et al. [14] recently proposed an
essential structural role of the REV1 protein in mutagenic
bypass in assembling DNA polymerase j with DNA polymer-
ase N. Protein tags might interfere with protein^protein inter-
actions and the intact form of REV1 protein is most appro-
priate for investigations of these interactions, a next step in
elucidating the molecular mechanisms of mutagenesis.
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